| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |